Pulmatrix Stock Plummets 9.5% After Uncertain Merger With Eos SENOLYTIX
Pulmatrix’s stock plunges after announcing a merger with Eos SENOLYTIX, raising doubts about a clear value add and the company’s fragile liquidity.
3 minutes to read
PULMATRIX INC
Pulmatrix (PULM) Soars 9.79% as Investor Confidence Rises in Respiratory Biotech
Pulmatrix (PULM) jumps 9.79% as investors rally around its clinical‑stage respiratory pipeline, fueled by FDA Fast‑Track momentum and new gene‑editing partnerships.
3 minutes to read